A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide

NCT05232708 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers (Diabetes Mellitus, Type 2)

Interventions

DRUG: Semaglutide B, 1.34 mg/mL
DRUG: Semaglutide D, 1.0 mg/mL
DRUG: Semaglutide D, 1.0 mg/mL
DRUG: Semaglutide B, 1.34 mg/mL

Sponsor

Novo Nordisk A/S